1.
Yüksel Ürün
@DrYukselUrun
If you told me 2 decades ago that @KidneyCancerDoc was going to change the face of #kidneycancer tx, I would have … twitter.com/i/web/status/1…
2.
Yüksel Ürün
@DrYukselUrun
TMB is not perfect to predict immunotherapy response
Mutations in single-copy regions and those present in multipl… twitter.com/i/web/status/1…
Mutations in single-copy regions and those present in multipl… twitter.com/i/web/status/1…
Retweet of status by @DrYukselUrun
3.
4.
5.
6.
7.
Yüksel Ürün
@DrYukselUrun
The power of Evidence Based Medicine twitter.com/DrYukselUrun/s…
Retweet of status by @Angrybird_RadOn
Yüksel Ürün
@DrYukselUrun
#radiation induced fatigue:
Mediated by β-Endorphin and might be reversed by opiate antagonists such as… twitter.com/i/web/status/1…
Mediated by β-Endorphin and might be reversed by opiate antagonists such as… twitter.com/i/web/status/1…
Yüksel Ürün
@DrYukselUrun
A beautiful fall day at Harvard Medical School pic.twitter.com/tuCbJAnaju
Retweet of status by @harvardmed
Yüksel Ürün
@DrYukselUrun
Comparison of real-world 1st-Line Ipi/Nivo or Axi/Pembro in Metastatic Clear Cell RCC
Favorable risk: axi/pembro p… twitter.com/i/web/status/1…
Favorable risk: axi/pembro p… twitter.com/i/web/status/1…
Yüksel Ürün
@DrYukselUrun
Reviewer 2: Accepted with minor corrections
Me
@FenixLumiere @OncoAlert
pic.twitter.com/ziRbZV6O8j
Me
@FenixLumiere @OncoAlert
pic.twitter.com/ziRbZV6O8j
Retweet of status by @DrYukselUrun
8.
9.
10.
11.
Yüksel Ürün
@DrYukselUrun
Probably the most awaited trial #ESMO22. CODEBREAK200 (sotorasib vs doc in 2/3L NSCLC)
PFS HR 0.66 (5.6 vs 4.5 m /… twitter.com/i/web/status/1…
PFS HR 0.66 (5.6 vs 4.5 m /… twitter.com/i/web/status/1…
Retweet of status by @JulienMazieres
Yüksel Ürün
@DrYukselUrun
Transitions from cytotoxic therapies to individualized therapies: New tumor agnostic approval by @US_FDA
FDA App… twitter.com/i/web/status/1…
FDA App… twitter.com/i/web/status/1…
Yüksel Ürün
@DrYukselUrun
A post hoc analysis of the phase 3 OAK trial:
Patients with non–small cell lung cancer and a low baseline neutrop… twitter.com/i/web/status/1…
Patients with non–small cell lung cancer and a low baseline neutrop… twitter.com/i/web/status/1…
Yüksel Ürün
@DrYukselUrun
SAKK 09/10 Trial:
Decipher Genomic Classifier identifies patients at highest risk of disease progression and who… twitter.com/i/web/status/1…
Decipher Genomic Classifier identifies patients at highest risk of disease progression and who… twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
